The Expurgo Protocol: Initial Results

Originally posted at Dispatches from Reality, by Scipio Eruditus. dfreality.substack.com

An update on our initial findings and current research…

“The brain is the organ of DESTINY.

It holds within its humming mechanism secrets that will determine the future of the human race.”

— Wilder Penfield, Neurosurgeon

Previous Entries

THE FORCED EVOLUTION OF HUMANITY: FIRST-HAND EVIDENCE OF NANOTECHNOLOGY WITHIN THE BLOOD OF THE INJECTED AND INFECTED

DETOXING DARPA’S DEVICES: THE EXPURGO PROTOCOL

THE MASS POISONING OF AMERICA: A CASE STUDY

CHAFF & COUNTERMEASURES

The Borg Initiative

I – Status Update

The LORD answered my prayers, and through the assistance of a close family member, I have been able to acquire a dark-field microscope of my own. This will allow me to significantly increase the amount of testing myself and my research partner, Dr. S, will be able to do. This week’s articles will be a bit leaner than usual as result, as I will be focusing on doing live blood analysis, testing new patients, and pushing out our latest findings. You should expect to see multiple smaller posts in your inbox this week.

We also have several new patients, both the jabbed and unjabbed, who show clear signs of nanotechnology infection. This includes myself, and my pregnant wife. Beyond the very disturbing nature of these findings, this knowledge has forced me to make some rather dramatic changes in how I spend my time, particularly in regards to how much I time I will be spending around technology in general going forward. My response times to your comments may take a bit longer than usual as a result. Rest assured, my desire to end this diabolical threat with God-given, natural medicine is even stronger now than it was before.

We have several patients running the Expurgo Protocol in either a modified or complete form, including myself & my wife, and we eagerly look forward to publishing those results in the coming weeks.

II – Blood Analysis

A. Legend

Graphene Oxide – GO

Graphene Nanocrystals – GNC

Graphene Hydrogel – GHG

Graphene Quantum Dots – GQD

Hydrogel Nanoribbons – HNR (Previously referred to as Hydrogel Filaments)

Hydrogel Nanostructure – HNS

B. Preparation & Methodologies

These two blood samples were collected from our former control patient, an unjabbed 61 year old male (This sample was taken on 8/18/2023). The patient has not had any sexual contact in the last 3 years. The patient has no history of intravenous drug use (IVDU). The patient was mandated by his employer to undergo routine PCR swap tests in 2021, but has not taken any since.

This patient had not taken any injectable medications since 2020 until the last week of August. The patient had a minor medical episode and had to be taken to the emergency room at his local hospital. He received 15 mg of Ketorolac Tromethamine (or Toradol), 1 liter of Sodium Chloride (or Saline), and 4 mg of Ondansetron (or Zofran), administered intravenously. He also received 3 tablets of Tylenol, administered orally. These are some of the most commonly administered drugs in ER’s across the world.

After this hospital visit, the patient presented the telltale signs of nanotechnology exposure, seen in his previous blood sample. (See The Mass Poisoning of America: A Case Study.) Our patient began the Expurgo Protocol on 9/11/2023, and the first week’s sample was collected and analyzed on 9/18/2023. The second week’s sample was collected and analyzed on 9/27/2023.

Our glass slides were brand new; they were also sterilized and washed with 70% Isopropyl Alcohol before use. We used a brand new lancet to acquire a drop of blood via the finger.

C. Week #1

(Image: C1)

The poor morphology of the patient’s blood cells is still seen in this sample, particularly around around the hydrogel nanoribbons and hydrogel nanostructures seen in the blood. There are, however, increased signs of monocytes, a type of white blood cell. This is a good sign, as the monocytes are seen here dissolving damaged cells, as well as the hydrogel structures we still see in the blood.

(Image: C2)

(Image: C3)

(Image: C4)

(Image: C5)

(Image: C6)

These are very clearly not air bubbles.

There are several hydrogel nanoislands with graphene nanocrystals visible within them. The formation of graphene quantum dots can be seen quite clearly in the various nanoislands displayed above. The nanostructures have significantly advanced in their construction since the last sample on 9/5/2023 was taken. There are certainly some striking images captured here; particularly C3, which captures what appears to be a hydrogel nanostructure breaking out of an egg-like hydrogel bubble.

(Image: C7)

This is a textbook example of a fully formed hydrogel nanostructure, with graphene quantum dots quite visible within it.

(Image: C8)

The single hydrogel nanoribbon seen in this sample is in a visibly decrepit state, as seen above. Monocyte activity can be seen in the area around the nanoribbon.

D. Week #2

(Image: D1)

Generally, the morphology of this blood sample is still not healthy. That being said, the sample as a whole does have a higher amount of healthy blood cells as compared to the patient’s previous samples.

(Image: D2)

(Image: D3)

(Image: D4)

(Image: D5)

(Image: D6)

(Image: D7)

Hydrogel nanoribbons (three of which can be seen in this sample) are in a much more degraded state than last week. Additionally, significant monocyte activity can be seen in the vicinity of these ribbons as they continue to disassemble in the blood.

Perhaps most importantly, hydrogel nanoislands and hydrogel nanostructures are not seen in this week’s sample. The reasons for this could admittedly be twofold, and they are not necessarily mutually exclusive: either the protocol is working to dissolve these substances, and/or the hydrogel has been fully consumed in order to create the developed nanoribbons we see above.

III – Conclusions

While the Expurgo Protocol has not been proven to fully detox these nanomaterials yet, we believe it has shown promising early results. The degraded state of these nanostructures and nanoribbons has very likely left them in a nonfunctional state. (This is admittedly an assumption, and should be confirmed via EMF signals testing, which is one of the next steps in expanding our diagnostic methodologies.) The nanomaterials they are composed of still pose a general health risk due to the cytotoxicity of these materials. That said, the second week’s results are still promising given the fact that the progression of these technologies has slowed down, and the degradation of the nanoribbons has significantly progressed in between samples. The lack of hydrogel nanoislands and nanostructures within the second sample are also another positive development.

Substances like EDTA have reportedly been able to break down these structures. It is impossible, however, to overlook the fact that Big Pharmakeia entirely controls the creation and distribution of patented compounds such as EDTA or Plaquex. That’s before we even get into the exorbitant price of these treatments (according to those who have received treatments of EDTA, it is $1000 a pop as a weekly treatment). This of course all but precludes those but the wealthiest among us from accessing this treatment.

My research partner and I are not discounting that certain pharmaceuticals have shown some early promise in dealing with these nanostructures, but due to the nature of the threat we face, such options are a last resort. The potentiating effect of these drugs with the known nanomaterials we have discussed have not been explored, and the long term effects of routine treatments with such compounds is unknown. Therefore, given the widespread adulteration of our medicine with nanomaterials and nanotechnology, such compounds can simply not be trusted at this point, and are not a sufficient answer to threat we all face.

The cure must not cause more harm than the disease itself, and this bedrock medical principal remains foremost in our minds.

Crucially, without changes to the fundamental biochemistry of a patient’s blood, the structures have reappeared; even after IV EDTA. Without identifying the totality of the threat vectors of this cutting-edge weapons platform, we find the idea that one pharmaceutical drug will be capable of tackling all of the various aspects of these nanoweapons seriously dubious. Our hope is that the Expurgo Protocol will fully address the host of nanomaterials that these shots are made of via our holistic approach, with a focus upon the mechanisms of actions to degrade and eventually detox these vile substances.

“Be strong and of a good courage, FEAR NOT, nor be afraid of them: for the Lord thy God, he it is that doth go with thee; he will not fail thee, nor forsake thee.”

— Deuteronomy 31:6 KJV

Further Research

Nanotechnology Applications for Combat Casualty Care by Homeland Defense & Security Information Analysis Center (HDAIC)

Future Strategic Issues/Future Warfare [Circa 2025] by Dennis M. Bushnell, Chief Scientist, NASA-Langley Research Center

Graphene nanoribbons initiated from molecularly derived seeds by Way et al.

Transformation of a graphene nanoribbon into a hybrid 1D nanoobject with alternating double chains and polycyclic regions by Sinitsa et al.

Nanoribbon self-assembly and hydrogel formation from an NOctanoyl octapeptide derived from the antiparallel β-Interface of a protein homotetramer by Rani et al.

Graphene Oxide Nanoribbon Hydrogel: Viscoelastic Behavior and Use as a Molecular Separation Membrane by Choi et al.

As an Amazon Associate I Earn from Qualifying Purchases

Click to visit the TBP Store for Great TBP Merchandise